Batzer A G, Blaikie P, Nelson K, Schlessinger J, Margolis B
Department of Pharmacology, New York University Medical Center, New York, USA.
Mol Cell Biol. 1995 Aug;15(8):4403-9. doi: 10.1128/MCB.15.8.4403.
Shc is an SH2 domain protein that is tyrosine phosphorylated in cells stimulated with a variety of growth factors and cytokines. Once phosphorylated, Shc binds the Grb2-Sos complex, leading to Ras activation. Shc can interact with tyrosine-phosphorylated proteins by binding to phosphotyrosine in the context of an NPXpY motif, where pY is a phosphotyrosine. This is an unusual binding site for an SH2 domain protein whose binding specificity is usually controlled by residues carboxy terminal, not amino terminal, to the phosphotyrosine. Recently we identified a second region in Shc, named the phosphotyrosine interaction (PI) domain, and we have found it to be present in a variety of other cellular proteins. In this study we used a dephosphorylation protection assay, competition analysis with phosphotyrosine-containing synthetic peptides, and epidermal growth factor receptor (EGFR) mutants to determine the binding sites of the PI domain of Shc on the EGFR. We demonstrate that the PI domain of Shc binds the LXNPXpY motif that encompasses Y-1148 of the activated EGFR. We conclude that the PI domain imparts to Shc its ability to bind the NPXpY motif.
Shc是一种含有SH2结构域的蛋白质,在受到多种生长因子和细胞因子刺激的细胞中会发生酪氨酸磷酸化。一旦磷酸化,Shc就会结合Grb2-Sos复合物,导致Ras激活。Shc可以通过在NPXpY基序的背景下与磷酸酪氨酸结合,从而与酪氨酸磷酸化的蛋白质相互作用,其中pY是磷酸酪氨酸。这对于一个SH2结构域蛋白来说是一个不寻常的结合位点,其结合特异性通常由磷酸酪氨酸羧基末端而非氨基末端的残基控制。最近,我们在Shc中鉴定出了第二个区域,称为磷酸酪氨酸相互作用(PI)结构域,并且我们发现它存在于多种其他细胞蛋白中。在本研究中,我们使用了去磷酸化保护分析、与含磷酸酪氨酸的合成肽的竞争分析以及表皮生长因子受体(EGFR)突变体来确定Shc的PI结构域在EGFR上的结合位点。我们证明,Shc的PI结构域结合包含活化EGFR的Y-1148的LXNPXpY基序。我们得出结论,PI结构域赋予Shc结合NPXpY基序的能力。